Zhejiang Public Welfare Technology Application Research Project(Grant No.2015C33285);Zhejiang Provincial Natural Science Foundation Project(Grant No.Y14H300005)
Carfilzomib has become a new choice for patients with multiple myeloma(MM).However, the use of carfilzomib single-agent or in combination with other agents in MM patients is not explicitly clarified in clinical prac...